Use este identificador para citar ou linkar para este item: http://repositorio.ufla.br/jspui/handle/1/58454
Título: Growth differentiation factor 11 delivered by dairy lactococcus lactis strains modulates inflammation and prevents mucosal damage in a mice model of intestinal mucositis
Palavras-chave: Intestinal inflammation
5-fluorouracil
Lactic acid bacteria
DNA delivery
Gene therapy
Data do documento: 2023
Editor: Frontiers
Citação: AMÉRICO, M. F. et al. Growth differentiation factor 11 delivered by dairy lactococcus lactis strains modulates inflammation and prevents mucosal damage in a mice model of intestinal mucositis. Frontiers in Microbiology, [S.l.], v. 14, 2023.
Resumo: Mucositis is an inflammation of the gastrointestinal mucosa that debilitate the quality of life of patients undergoing chemotherapy treatments. In this context, antineoplastic drugs, such as 5-fluorouracil, provokes ulcerations in the intestinal mucosa that lead to the secretion of pro-inflammatory cytokines by activating the NF-κB pathway. Alternative approaches to treat the disease using probiotic strains show promising results, and thereafter, treatments that target the site of inflammation could be further explored. Recently, studies reported that the protein GDF11 has an anti-inflammatory role in several diseases, including in vitro and in vivo results in different experimental models. Hence, this study evaluated the anti-inflammatory effect of GDF11 delivered by Lactococcus lactis strains NCDO2118 and MG1363 in a murine model of intestinal mucositis induced by 5-FU. Our results showed that mice treated with the recombinant lactococci strains presented improved histopathological scores of intestinal damage and a reduction of goblet cell degeneration in the mucosa. It was also observed a significant reduction of neutrophil infiltration in the tissue in comparison to positive control group. Moreover, we observed immunomodulation of inflammatory markers Nfkb1, Nlrp3, Tnf, and upregulation of Il10 in mRNA expression levels in groups treated with recombinant strains that help to partially explain the ameliorative effect in the mucosa. Therefore, the results found in this study suggest that the use of recombinant L. lactis (pExu:gdf11) could offer a potential gene therapy for intestinal mucositis induced by 5-FU.
URI: https://www.frontiersin.org/articles/10.3389/fmicb.2023.1157544/full
http://repositorio.ufla.br/jspui/handle/1/58454
Aparece nas coleções:DMV - Artigos publicados em periódicos

Arquivos associados a este item:
Não existem arquivos associados a este item.


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.